The Institute for Systems Biology has appointed Robert Lipshutz to be chief business officer and senior vice president for strategic partnerships.
Lipshutz spent nearly two decades at Affymetrix in various roles, focusing on business development, licensing, diagnostics, and emerging markets, and most recently was Affy's senior vice president for corporate development.
Illumina said last this week that Christian Cabou, who is senior vice president, general counsel and secretary, has notified the company that he plans to retire sometime early next year.
Cabou has worldwide responsibility for all of the company's legal and intellectual property matters and is also Illumina's code of ethics compliance officer. Prior to joining Illumina in 2006, Cabou was general counsel for GE Global Research.
GenMark Diagnostics said last week that Stephen Worland has been appointed to its board of directors.
Worland is currently president and CEO of Effector Therapeutics. He was president and CEO and a director of Anadys Pharmaceuticals from 2007 until the company was acquired by Roche in 2011.